Latest news with #Titomic
Yahoo
a day ago
- Business
- Yahoo
ASX Growth Companies With High Insider Ownership In July 2025
As the ASX 200 begins the new financial year on a flat note, with sectors like Utilities and IT showing modest gains, investors are keenly observing market movements to identify promising opportunities. In this environment, growth companies with high insider ownership often stand out as they can signal strong confidence from those who know the business best, potentially offering resilience and strategic advantage amidst fluctuating market conditions. Name Insider Ownership Earnings Growth Titomic (ASX:TTT) 11.2% 77.2% Newfield Resources (ASX:NWF) 31.5% 72.1% Image Resources (ASX:IMA) 22.3% 79.9% Fenix Resources (ASX:FEX) 21.1% 53.4% Echo IQ (ASX:EIQ) 18% 51.4% Cyclopharm (ASX:CYC) 11.3% 97.8% Brightstar Resources (ASX:BTR) 11.6% 106.7% AVA Risk Group (ASX:AVA) 15.4% 108.2% Alfabs Australia (ASX:AAL) 10.8% 41.3% Adveritas (ASX:AV1) 19.9% 88.8% Click here to see the full list of 94 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★★☆ Overview: Ltd is an online retailer based in Australia with a market capitalization of A$384.35 million. Operations: The company generates revenue through its operations in Australia, with A$309.36 million from Kogan Parent and A$9.96 million from Mighty Ape, as well as in New Zealand, earning A$40.02 million from Kogan Parent and A$124.88 million from Mighty Ape. Insider Ownership: 20.8% is poised for significant earnings growth, forecasted at 34.5% annually, outpacing the Australian market's 10.9%. Despite a dip in profit margins to 0.4% from last year's 1.4%, the company trades at a substantial discount of 63.4% below its estimated fair value, presenting potential value opportunities. Recent executive changes include Belinda Cleminson's appointment as Company Secretary, enhancing corporate governance with her extensive experience in listed companies. Take a closer look at potential here in our earnings growth report. Our comprehensive valuation report raises the possibility that is priced lower than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★★★ Overview: Meeka Metals Limited focuses on the exploration and development of gold properties in Western Australia, with a market cap of A$422.78 million. Operations: Meeka Metals Limited's revenue segments are currently not specified in the provided text. Insider Ownership: 12% Meeka Metals is set for strong growth, with earnings forecasted to rise 54.14% annually and revenue expected to grow at 56.1% per year, significantly outpacing the Australian market. Despite generating less than US$1 million in revenue (A$329K), it trades at a 28.6% discount to its estimated fair value. A recent A$60 million equity offering supports expansion efforts, while high insider ownership aligns management interests with shareholders despite no recent insider trading activity noted. Get an in-depth perspective on Meeka Metals' performance by reading our analyst estimates report here. Insights from our recent valuation report point to the potential undervaluation of Meeka Metals shares in the market. Simply Wall St Growth Rating: ★★★★★☆ Overview: PYC Therapeutics Limited is an Australian drug-development company focused on discovering and developing novel RNA therapeutics for genetic diseases, with a market capitalization of A$755.32 million. Operations: The company generates revenue of A$24.99 million from its activities in the discovery and development of novel RNA therapeutics for genetic diseases. Insider Ownership: 35.9% PYC Therapeutics is poised for growth, with earnings expected to increase by 24.3% annually and become profitable within three years, outperforming the market. Despite recent shareholder dilution, it trades at a significant discount to its estimated fair value. Insider ownership remains high, aligning management interests with shareholders. Recent developments include dosing in a Phase 1a trial of PYC-003, indicating progress in their clinical pipeline and potential future revenue catalysts despite slower revenue growth forecasts of 12.6% annually. Unlock comprehensive insights into our analysis of PYC Therapeutics stock in this growth report. The analysis detailed in our PYC Therapeutics valuation report hints at an inflated share price compared to its estimated value. Take a closer look at our Fast Growing ASX Companies With High Insider Ownership list of 94 companies by clicking here. Seeking Other Investments? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:KGN ASX:MEK and ASX:PYC. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
18-06-2025
- Business
- Yahoo
ASX Growth Stocks With High Insider Ownership To Watch
As the Australian market remains relatively flat, with the ASX hovering close to 8,542 points and sectors like IT outperforming while Materials face pressure, investors are closely watching potential tax reforms that could impact future economic conditions. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment of interests between management and shareholders. Name Insider Ownership Earnings Growth Titomic (ASX:TTT) 11.2% 77.2% Newfield Resources (ASX:NWF) 31.5% 72.1% Image Resources (ASX:IMA) 20.6% 79.9% Fenix Resources (ASX:FEX) 21.1% 53.4% Echo IQ (ASX:EIQ) 18% 65.9% Cyclopharm (ASX:CYC) 11.3% 97.8% Brightstar Resources (ASX:BTR) 11.6% 106.7% Alfabs Australia (ASX:AAL) 10.8% 41.3% Adveritas (ASX:AV1) 21% 88.8% Acrux (ASX:ACR) 15.5% 106.9% Click here to see the full list of 94 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Aurelia Metals Limited is involved in the exploration and production of mineral properties in Australia, with a market cap of A$516.23 million. Operations: The company's revenue is derived from its operations at the Hera Mine (A$5.98 million), Peak Mine (A$245.13 million), and Dargues Mine (A$73.90 million). Insider Ownership: 23.9% Revenue Growth Forecast: 14.6% p.a. Aurelia Metals is poised for significant growth, with earnings expected to rise 45.29% annually, outpacing the Australian market's 11.6%. Revenue growth is projected at 14.6% per year, surpassing the market average of 5.6%. The stock trades at a substantial discount to its estimated fair value, suggesting potential upside. Recent events include an Analyst/Investor Day focusing on strategic growth opportunities and a change in registered office location to Brisbane, enhancing operational efficiency. Click to explore a detailed breakdown of our findings in Aurelia Metals' earnings growth report. Our valuation report unveils the possibility Aurelia Metals' shares may be trading at a premium. Simply Wall St Growth Rating: ★★★★★☆ Overview: PWR Holdings Limited specializes in the design, prototyping, production, testing, validation, and sale of cooling products and solutions across various international markets with a market cap of A$661.71 million. Operations: PWR Holdings Limited generates revenue from two main segments: PWR C&R, contributing A$46.48 million, and PWR Performance Products, contributing A$109.04 million. Insider Ownership: 13.3% Revenue Growth Forecast: 13.4% p.a. PWR Holdings is positioned for robust growth, with earnings anticipated to increase by 24.56% annually, exceeding the Australian market's average of 11.6%. Analysts agree on a potential stock price rise of 25.6%, while it currently trades at a discount to its fair value estimate. Insider confidence is evident with substantial share purchases and no significant sales over the past three months, reinforcing positive sentiment around its future performance. Take a closer look at PWR Holdings' potential here in our earnings growth report. The analysis detailed in our PWR Holdings valuation report hints at an deflated share price compared to its estimated value. Simply Wall St Growth Rating: ★★★★★☆ Overview: Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that develops and commercializes therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases across Australia, Belgium, Japan, Switzerland, and the United States, with a market cap of A$8.71 billion. Operations: The company's revenue is primarily derived from three segments: Therapeutics (A$9.35 million), Precision Medicine (A$771.11 million), and Manufacturing Solutions (A$2.75 million). Insider Ownership: 14.9% Revenue Growth Forecast: 19.8% p.a. Telix Pharmaceuticals is experiencing significant growth, with earnings expected to increase by 32.8% annually, outpacing the Australian market average. The company trades at a considerable discount to its fair value estimate and shows no substantial insider selling recently, indicating confidence in its prospects. Recent approvals of Telix's prostate cancer imaging agents across Europe and the U.S., including Illuccix® and Gozellix®, enhance its market presence and support future revenue expansion. Click here and access our complete growth analysis report to understand the dynamics of Telix Pharmaceuticals. Insights from our recent valuation report point to the potential undervaluation of Telix Pharmaceuticals shares in the market. Investigate our full lineup of 94 Fast Growing ASX Companies With High Insider Ownership right here. Contemplating Other Strategies? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:AMI ASX:PWH and ASX:TLX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
21-04-2025
- Business
- Yahoo
Retail investors account for 51% of Titomic Limited's (ASX:TTT) ownership, while institutions account for 19%
The considerable ownership by retail investors in Titomic indicates that they collectively have a greater say in management and business strategy A total of 25 investors have a majority stake in the company with 49% ownership Insider ownership in Titomic is 11% This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. A look at the shareholders of Titomic Limited (ASX:TTT) can tell us which group is most powerful. The group holding the most number of shares in the company, around 51% to be precise, is retail investors. Put another way, the group faces the maximum upside potential (or downside risk). And institutions on the other hand have a 19% ownership in the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Let's delve deeper into each type of owner of Titomic, beginning with the chart below. See our latest analysis for Titomic Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. As you can see, institutional investors have a fair amount of stake in Titomic. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Titomic's earnings history below. Of course, the future is what really matters. It would appear that 8.5% of Titomic shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Regal Partners Limited is currently the largest shareholder, with 8.5% of shares outstanding. Maybank Securities Pte Ltd, Asset Management Arm is the second largest shareholder owning 7.6% of common stock, and Macquarie Group, Ltd., Banking & Securities Investments holds about 5.3% of the company stock. Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is some analyst coverage of the stock, but it could still become more well known, with time. The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in Titomic Limited. It has a market capitalization of just AU$298m, and insiders have AU$33m worth of shares in their own names. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently. The general public, mostly comprising of individual investors, collectively holds 51% of Titomic shares. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio. It seems that Private Companies own 9.4%, of the Titomic stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company. It's always worth thinking about the different groups who own shares in a company. But to understand Titomic better, we need to consider many other factors. Case in point: We've spotted 3 warning signs for Titomic you should be aware of, and 1 of them is potentially serious. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
31-03-2025
- Business
- Yahoo
We're Not Very Worried About Titomic's (ASX:TTT) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. Indeed, Titomic (ASX:TTT) stock is up 277% in the last year, providing strong gains for shareholders. But while history lauds those rare successes, those that fail are often forgotten; who remembers So notwithstanding the buoyant share price, we think it's well worth asking whether Titomic's cash burn is too risky. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). Let's start with an examination of the business' cash, relative to its cash burn. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at December 2024, Titomic had cash of AU$24m and such minimal debt that we can ignore it for the purposes of this analysis. In the last year, its cash burn was AU$9.3m. That means it had a cash runway of about 2.6 years as of December 2024. That's decent, giving the company a couple years to develop its business. You can see how its cash balance has changed over time in the image below. See our latest analysis for Titomic At first glance it's a bit worrying to see that Titomic actually boosted its cash burn by 8.6%, year on year. On a more positive note, the operating revenue improved by 244% over the period, offering an indication that the expenditure may well be worthwhile. If that revenue does keep flowing reliably, then the company could see a strong improvement in free cash flow simply by reducing growth expenditure. We think it is growing rather well, upon reflection. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years. While Titomic seems to be in a decent position, we reckon it is still worth thinking about how easily it could raise more cash, if that proved desirable. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Many companies end up issuing new shares to fund future growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. Titomic has a market capitalisation of AU$325m and burnt through AU$9.3m last year, which is 2.9% of the company's market value. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply. As you can probably tell by now, we're not too worried about Titomic's cash burn. For example, we think its revenue growth suggests that the company is on a good path. While its increasing cash burn wasn't great, the other factors mentioned in this article more than make up for weakness on that measure. Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. On another note, Titomic has 3 warning signs (and 1 which shouldn't be ignored) we think you should know about. If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
